Live Breaking News & Updates on B Cell And Double Hit
Stay updated with breaking news from B cell and double hit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses of ZYNLONTA® in Relapsed/Refractory DLBCL streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
LAUSANNE, Switzerland, June 09, 2023 (GLOBE NEWSWIRE) ADC Therapeutics SA (NYSE: ADCT) today announced updated results from LOTIS-2, the pivotal Phase 2 clinical trial of ZYNLONTA® (loncastuximab tesirine-lpyl) in ....